Shorted
Nanosonics logo

NAN

Nanosonics

Health Care Equipment & Services

Nanosonics is an Australian company specializing in infection control and decontamination technologies. It aims to be a global leader by providing economical and safe solutions that prevent the transmission of infections. The company focuses on research, development, and commercialization of innovative technologies in the healthcare sector.

Infection Control
Healthcare
Innovation
ASX

Shorted

short percentage10.05%
reported shorts30.5M
shares on issue303.346M

About

industry

Health Care Equipment & Services

address

Building A, Level 1, 7 - 11 Talavera Road, MACQUARIE PARK, NSW, AUSTRALIA, 2113

Connect

Key Metrics

market cap
$1.03B
p/e ratio48.57
eps$0.07

More Health Care Equipment & Services Stocks

Other shorted stocks in this sector

Short Position Trends

Track bearish sentiment and short interest over time

Historical Price Data

View stock price movements, volume, and trading patterns

Industry & Focus

Infection Control
Healthcare
Innovation
ASX
Technology

Company Overview

AI-generated company summary

Nanosonics is an Australian company specializing in infection control and decontamination technologies. It aims to be a global leader by providing economical and safe solutions that prevent the transmission of infections. The company focuses on research, development, and commercialization of innovative technologies in the healthcare sector.

Company History

Nanosonics was founded with the mission to revolutionize infection control in healthcare settings. Over the years, it has developed and commercialized several innovative products, gaining recognition in the global market. The company has expanded its operations internationally, establishing a strong presence in key regions such as North America, Europe, and Asia Pacific.

Competitive Advantages

Nanosonics' competitive advantages include its focus on innovative infection control technologies, a strong global presence, and a commitment to research and development. The company's products are known for their safety, efficacy, and cost-effectiveness, which sets them apart in the healthcare industry.

Risk Factors

  • Regulatory changes in healthcare
  • Market competition
  • Dependence on key markets

Recent Developments

Last 6 months

In the past six months, Nanosonics has released its 2025 Annual Report and financial results, highlighting continued growth and expansion in international markets.

Key People

Leadership team at Nanosonics

SS

Steven Sargent

Chairman

Steven Sargent joined the Board in July 2016 and was appointed Chairman in July 2022. He has extensive experience from his 22-year career at General Electric, leading businesses in healthcare, energy, and financial services.

JB

Jason Burriss

CFO

Jason Burriss is the Chief Financial Officer at Nanosonics, bringing a wealth of financial expertise to the company.

Financial Reports

109 reports available

Appendix 4E

Annual ResultsAug 26, 2025via asx_announcements

2025 Full Year Results Investor Presentation

Full Year ResultsAug 26, 2025via asx_announcements

2025 Full Year Financial Results

Full Year ResultsAug 26, 2025via asx_announcements

2025 Annual Report

Annual ReportAug 26, 2025via asx_announcements

FY25 Full Year Results webinar notification

Full Year ResultsAug 7, 2025via asx_announcements

2025 Half Year Financial Results

Half Year ResultsFeb 20, 2025via asx_announcements

2025 Half Year Financial Results Investor Presentation

Half Year ResultsFeb 20, 2025via asx_announcements

Appendix 4D and Half Year Accounts

Half Year ResultsFeb 20, 2025via asx_announcements

2025 Half Year Results conference call notification

Half Year ResultsJan 24, 2025via asx_announcements

2024 Full Year Financial Results

Full Year ResultsAug 27, 2024via asx_announcements

Showing 10 of 109 reports